Efficacy and Safty of Camrelizumab Plus S-1 Maintenance After First-line Induction Chemotherapy for GC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma. (NCT05170542) | Peking Union Medical College Hospital | 2021-12-24 |
Track Efficacy and Safty of Camrelizumab Plus S-1 Maintenance After First-line Induction Chemotherapy for GC automatically
Every clearance here is in the API, with alerts when new ones post.